Article info

Download PDFPDF

Predictors of long-term progression-free survival in patients with ovarian cancer treated with niraparib in the PRIMA/ENGOT-OV26/GOG-3012 study

Authors

  1. Correspondence to Dr Whitney S Graybill, Medical University of South Carolina, 96 Jonathan Lucas Street, Charleston, SC 29425, USA; graybill{at}musc.edu
View Full Text

Citation

Graybill WS, Pardo Búrdalo B, O’Malley DM, et al
Predictors of long-term progression-free survival in patients with ovarian cancer treated with niraparib in the PRIMA/ENGOT-OV26/GOG-3012 study

Publication history

  • Received January 31, 2024
  • Accepted April 19, 2024
  • First published July 1, 2024.
Online issue publication 
July 01, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.